The largest database of trusted experimental protocols

11 protocols using ril 2

1

Modulating immune responses with IL-2C

Check if the same lab product or an alternative is used in the 5 most similar protocols
The monoclonal antibodies against mouse IL-2, CD8, and NK1.1 were obtained from hybridoma clones, S4B6-1, 53-6.72, and PK-136, respectively (American Type Culture Collection, USA). The recombinant mouse IL-2 (rIL-2) was purchased from BioLegend (USA). For the preparation of IL-2C, 1.5 μg of rIL-2 and 15 μg of anti-IL-2 were mixed in vitro, and then IL-2C was i.p. injected two times per every week at 3-day or 4-day intervals from 100 days of age until endpoint. For the isotype control, the same amount of purified rat IgG2a (BioLegend) was used. For depletion of CD8+-T cells or NK-T cells and NK cells, 100 μg of anti-CD8 or anti-NK1.1 was i.p. injected two times per every week at 3-day or 4-day intervals from 100 days of age until endpoint. Equal volume of PBS was used as the control. The efficacies of these administrations were confirmed by flow cytometry.
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following monoclonal antibodies (mAbs) were used in cytometric studies (fluorochromes and clones in brackets): anti-CD3 (PE-Cy7, SK7), anti-CD4 (APC or PE-Cy5, RPAT4), anti-CD25 (PE, 2A3), anti-CD127 (PE-Cy7, AO19D5). Items were purchased from BD Biosciences, USA, or BioLegend, USA. Intracellular staining for Foxp3 (FITC, 206D) and IFN-γ (PerCP-Cy.5.5, B27) was performed with ready-to-use kits according to the manufacturer's suggestions (BioLegend, USA and BD Biosciences, USA, respectively). Additionally, the following reagents were used for the stimulation of cell cultures: anti-CD3 (clone UCHT1, eBioscience, USA), anti-CD28 (clone CD28.2, eBioscience, USA) antibodies, rIL-2 (BioLegend, USA), PMA (Sigma, Poland), ionomycin (Sigma, Poland), and GolgiStop (BD Biosciences, USA).
+ Open protocol
+ Expand
3

Splenic CD8 T Cell Activation and Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenic CD8 T cells were magnetically enriched using an AutoMACS pro (Miltenyi Biotec) to >95% purity per manufacturer's instructions. The cells were fluorescein-labeled with 5 μM carboxyfluorescein succinimidyl ester (CFSE) at 37° for 10', washed 3x with RPMI-1640 medium supplemented with 2-mercaptoethanol, L-glutamine, pyruvate, non-essential amino acids, and 10% fetal bovine serum (abbreviated as RP10 in the text). The cells were cultured at 2 × 105 cells/ml at a 1:1 ratio with α-CD3/α-CD28 immobilized on beads (Miltenyi), in the presence of combinations of 10 U/ml rIL-2, 10 ng/ml rIL-12 (Biolegend), and 10 ng/ml rIL-18 (Biolegend), as indicated, for up to 3 days. On each day of analysis, cells were stained for viability (LIVE/DEAD reagent, Invitrogen), as well as with surface and/or intracellular antibodies.
+ Open protocol
+ Expand
4

Adoptive Transfer of Tumor-Specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adoptive transfers were performed as described previously [25 (link)]. The number of transferred cells and the timing of transfer and infection are stated in each figure legend. For the experiments in Fig. 6 and Suppl. Fig. 3A, OT-Is and Pmel-Is were co-transferred into mice one day before implantation of B16F0s. Recipients were co-infected with MCMV-SL8 and MCMV-gp100 5 days after tumor implantation to expand both OT-Is and Pmel-Is. For in vitro activation, OT-Is were either taken from fresh or frozen naïve splenocytes (frozen in T cell media plus 10% DMSO) and enriched via magnetic negative CD8 selection as described above. Enriched cells were activated with anti-CD3/CD28 coated Dynabeads (ThermoFisher Scientific) following the manufacturer's protocol in T cell media containing 30 U/ml rIL-2 (Biolegend). Upon transfer, OT-Is were 90–100% alive (determined by Zombie Aqua™ Fixable Viability Kit [Biolegend]), 95–100% CD44hi (determined by anti-CD44 [clone IM7]), and had expanded 20–30 times.
+ Open protocol
+ Expand
5

Immunology Study in C57BL/6 Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were obtained from Japan SLC and maintained in specific pathogen-free conditions in our animal facility. All animal experiments were performed according to the protocols approved by the Institutional Animal Care and Use Committee at Waseda University (#2017-A007a, 2018-A090, 2019-A041, 2020-A057, 2021-A003, A22-007, and A23-007). We used 7- to 12-wk-old male or female C57BL/6 mice. Mouse rIL-1β, rIL-2, rIL-4, rIL-6, rIL-21, rIL-23, rTGF-β1, rCXCL13, and anti-ICOS (clone C398.4A) monoclonal Abs (mAbs) were obtained from BioLegend. Mouse rIL-12 and Cellstain CFSE (5- or 6-(N-Succinimidyloxycarbonyl)fluorescein 3’,6’-diacetate) were from Fujifilm Wako Pure Chemistry. mAbs to CD28 (clone 37.51), IL-2 (clone JES6-1A12), IL-4 (clone 11B11), IL-2Rα (clone PC-61.5.3), IL-2Rβ (clone TM-β1), and IFN-γ (clone XMG1.2) were from Bio X Cell. CH-223191, 6-formylindolo[3,2-b]carbazole (FICZ) and 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) were from Cayman Chemical.
+ Open protocol
+ Expand
6

Evaluating CACT Knockdown in PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs (2x105) were cultured in serum-free Accell siRNA delivery media (siRNA technologies; Dharmacon, Lafayette, CO, USA) supplemented with 300 U/mL rIL-2 (Biolegend) with 1 μM scramble siRNA or 1 μM CACT for 36hrs. At 72 hrs, knockdown was quantified by flow cytometry and treated with metabolites as indicated for an additional 48 hrs in Accell siRNA delivery media. At the end of day 5 in culture, αCD3/CD28 Dynabeads and FBS to a final concentration of 10% were added to stimulate the cells for 40hrs. After a total of 7 days in culture, the cells were harvested, Dynabeads removed and the cells were stained for flow cytometry.
+ Open protocol
+ Expand
7

Ginseng Extract Enhances NK Cell Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
KRG extract was used as CheongKwanJang (Korea Ginseng Corporation, Daejeon, Korea). KRG extract was made by decocting KRG roots cultivated over six years and contained ginsenoside Rg1, Rb1, and Rg3 (5 mg/g). KRG extract (50 mg/kg BW/10 mL) or water (control group) was orally administered daily after transplantation of SK-Hep1_Luc cells.
NK-92 cells (human NK cells, ATCC, CRL-2407) were maintained in alpha minimum essential medium (Gibco, Waltham, MA, USA) supplemented with 20% FBS (GW Vitek), 1% penicillin-streptomycin (GenDEPOT), 0.1 mM 2-mercaptoethanol (Sigma-Aldrich, Inc., St. Louis, MO, USA), and 100–200 U/mL rIL-2 (Biolegend, San Diego, CA, USA). NK cells (2 × 106 cells/100 μL) or phosphate-buffered saline (PBS; control group) were intraperitoneally injected twice a week beginning on day 20.
+ Open protocol
+ Expand
8

Characterization of Murine T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-mouse CD73 mAb (clone TY/23) and Rat IgG2a isotype control (clone 2A3) were purchased from BioX-Cell (West Lebanon, NH, USA). Anti-mouse mAbs for owcytometric analysis were used as described here. FITC-conjugated anti-CD4 (GK1.5), anti-CD8α (53 - 6.7), anti-CD11b (M1/70), and PE-conjugated anti-CD39 (Duha59), anti-IFN-γ (XMG1.2), APC-conjugated anti-CD73 (TY/11.8), anti-CD3 (17A2), and FITC-conjugated anti-CD45 (30-F11), and mouse recombinant Interleukin-2 (r-IL-2) were purchased from BioLegend (San Diego, CA USA). FcR blocking reagent was obtained from Miltenyi Biotec GmBH (Bergisch Gladbach, Germany). 7AAD (7-Aminoactinomycin D) and FVS-780 were purchased from Thermo-Fisher Scienti c (Waltham, MA USA) and BD Biosciences (Franklin Lakes, NJ USA), respectively.
+ Open protocol
+ Expand
9

Antibody-based Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-mouse CD73 mAb (clone TY/23) and Rat IgG2a isotype control (clone 2A3) were purchased from BioX-Cell (West Lebanon, NH, USA). Anti-mouse mAbs for owcytometric analysis were used as described here. FITC-conjugated anti-CD4 (GK1.5), anti-CD8α (53-6.7), anti-CD11b (M1/70), and PE-conjugated anti-CD39 (Duha59), anti-IFN-g (XMG1.2), APC-conjugated anti-CD73 (TY/11.8), anti-CD3 (17A2), and FITCconjugated anti-CD45 (30-F11), and mouse recombinant Interleukin-2 (r-IL-2) were purchased from BioLegend (San Diego, CA USA). FcR blocking reagent was obtained from Miltenyi Biotec GmBH (Bergisch Gladbach, Germany). 7AAD (7-Aminoactinomycin D) and FVS-780 were purchased from Thermo-Fisher Scienti c (Waltham, MA USA) and BD Biosciences (Franklin Lakes, NJ USA), respectively.
+ Open protocol
+ Expand
10

Antibody-based Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-mouse CD73 mAb (clone TY/23) and Rat IgG2a isotype control (clone 2A3) were purchased from BioX-Cell (West Lebanon, NH, USA). Anti-mouse mAbs for owcytometric analysis were used as described here. FITC-conjugated anti-CD4 (GK1.5), anti-CD8α (53-6.7), anti-CD11b (M1/70), and PE-conjugated anti-CD39 (Duha59), anti-IFN-g (XMG1.2), APC-conjugated anti-CD73 (TY/11.8), anti-CD3 (17A2), and FITCconjugated anti-CD45 (30-F11), and mouse recombinant Interleukin-2 (r-IL-2) were purchased from BioLegend (San Diego, CA USA). FcR blocking reagent was obtained from Miltenyi Biotec GmBH (Bergisch Gladbach, Germany). 7AAD (7-Aminoactinomycin D) and FVS-780 were purchased from Thermo-Fisher Scienti c (Waltham, MA USA) and BD Biosciences (Franklin Lakes, NJ USA), respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!